| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6006433 | Clinical Neurology and Neurosurgery | 2015 | 7 Pages |
Abstract
GTR offers the best prognosis for improved long-term survival. Adjuvant HD FSRT for cranio-cervical/clival chordomas significantly improves disease free survival though the long-term benefits on survival have yet to be established. Sacral chordomas are associated with a worse prognosis and poor long-term survival.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Raheel Ahmed, Arshin Sheybani, Arnold H. Menezes, John M. Buatti, Patrick W. Hitchon,